Natco Pharma's Q1 Results: Net profit zooms 31% to Rs 420 crore
The drugmaker said it has recorded consolidated total revenue of Rs 1160.2 crore for the first quarter, as against Rs 918.9 crore for the same period last year, reflecting a growth of 26.3 per cent.
Major drivers of business during the quarter were from formulation exports, strong growth in domestic business of both Pharma and Agro and steady sales from subsidiaries.(Image credit: PTI/file)